Recruiting IgA Nephropathy Studies in New Haven
About IgA Nephropathy Clinical Trials in New Haven
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 1 iga nephropathy clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 60 participants. Research is being sponsored by Calliditas Therapeutics AB. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in New Haven — FAQ
Are there iga nephropathy clinical trials in New Haven?
Yes, there are 1 iga nephropathy clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 1 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated March 2, 2026 from ClinicalTrials.gov